Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer
    Meeting Abstract

    Shen, S.; Safonov, A.; Bromberg, M.; Chen, Y.; Ahmed, M.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses
    Meeting Abstract

    O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Combined impact of primary tumor molecular profile and location in the relapse pattern of early-stage, microsatellite stable colorectal cancer
    Meeting Abstract

    Manca, P.; Kris, A.; Walch, H. S.; Fong, C.; Jee, J.; Pichotta, K.; Schultz, N.; Chatila, W. K.; Sanchez-Vega, F.; Yaeger, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quality of life in patients with malignant wounds treated at a wound care clinic
    Meeting Abstract

    Chen, A.; Dusza, S. W.; Bromberg, J.; Chandarlapaty, S.; Goldfarb, S. B.; Sanford, R. A.; Markova, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Use of an application that extracts and consolidates adverse events and concomitant medication data from clinical systems to increase clinical trial data entry efficiency, trust, and satisfaction
    Meeting Abstract

    Yuravlivker, L.; Kim, B. Y.; Buckley, M. T.; Bouvier, N.; Panchal, R.; Lengfellner, J. M.; Delgado, C.; Terzulli, S. L.; Sabbatini, P.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Utilization patterns and outcomes of radiotherapy for patients with germ cell tumor relapsing with brain metastases, with a focus on stereotactic radiosurgery
    Meeting Abstract

    Gui, C.; Funt, S. A.; Yu, Y.; Zinovoy, M.; Chen, L.; Yamada, Y.; Pike, L. R. G.; Feldman, D. R.; Imber, B. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Signatures of early plasticity in the histological transformation of lung cancer
    Meeting Abstract

    Rakhade, S.; Chen, M. F.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Chaudhary, O.; Xu, T.; Masilionis, I.; Falcon, C. J.; Egger, J. V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Jacobi, R.; Aggen, D. H.; McHugh, D. J.; Shah, N. J.; Carlo, M. I.; Keegan, N. M.; Gayadin, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save